MEDICLIN Aktiengesellschaft (MED) - Net Assets

Latest as of December 2025: €249.63 Million EUR ≈ $291.85 Million USD

Based on the latest financial reports, MEDICLIN Aktiengesellschaft (MED) has net assets worth €249.63 Million EUR (≈ $291.85 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€879.69 Million ≈ $1.03 Billion USD) and total liabilities (€630.06 Million ≈ $736.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Explore MEDICLIN Aktiengesellschaft (MED) cash conversion ratio to assess how effectively this company generates cash.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€249.63 Million
% of Total Assets	28.38%
Annual Growth Rate	4.3%
5-Year Change	36.39%
10-Year Change	37.49%
Growth Volatility	11.22

MEDICLIN Aktiengesellschaft - Net Assets Trend (2003–2025)

This chart illustrates how MEDICLIN Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Explore MED long-term investment intensity to see how much of total assets are deployed in long-term investments.

Annual Net Assets for MEDICLIN Aktiengesellschaft (2003–2025)

The table below shows the annual net assets of MEDICLIN Aktiengesellschaft from 2003 to 2025. For live valuation and market cap data, see MED company net worth.

Year	Net Assets	Change
2025-12-31	€249.63 Million ≈ $291.85 Million	+12.07%
2024-12-31	€222.74 Million ≈ $260.40 Million	+13.62%
2023-12-31	€196.03 Million ≈ $229.18 Million	-6.35%
2022-12-31	€209.32 Million ≈ $244.72 Million	+14.37%
2021-12-31	€183.02 Million ≈ $213.97 Million	+3.49%
2020-12-31	€176.85 Million ≈ $206.75 Million	-7.29%
2019-12-31	€190.75 Million ≈ $223.00 Million	-0.34%
2018-12-31	€191.40 Million ≈ $223.77 Million	+3.32%
2017-12-31	€185.26 Million ≈ $216.59 Million	+2.04%
2016-12-31	€181.56 Million ≈ $212.27 Million	+7.35%
2015-12-31	€169.14 Million ≈ $197.74 Million	+9.87%
2014-12-31	€153.95 Million ≈ $179.98 Million	+1.16%
2013-12-31	€152.19 Million ≈ $177.92 Million	-3.08%
2012-12-31	€157.02 Million ≈ $183.57 Million	-5.17%
2011-12-31	€165.59 Million ≈ $193.59 Million	+0.37%
2010-12-31	€164.99 Million ≈ $192.89 Million	+4.91%
2009-12-31	€157.26 Million ≈ $183.86 Million	+5.66%
2008-12-31	€148.84 Million ≈ $174.00 Million	+42.88%
2007-12-31	€104.17 Million ≈ $121.79 Million	+5.82%
2006-12-31	€98.44 Million ≈ $115.09 Million	+12.08%
2005-12-31	€87.83 Million ≈ $102.68 Million	+7.84%
2004-12-31	€81.45 Million ≈ $95.22 Million	-17.56%
2003-12-31	€98.80 Million ≈ $115.51 Million	--

Equity Component Analysis

This analysis shows how different components contribute to MEDICLIN Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 12539083800.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	€81.21 Million	32.62%
Common Stock	€47.50 Million	19.08%
Other Comprehensive Income	€-9.16 Million	-3.68%
Other Components	€129.39 Million	51.98%
Total Equity	€248.95 Million	100.00%

MEDICLIN Aktiengesellschaft Competitors by Market Cap

The table below lists competitors of MEDICLIN Aktiengesellschaft ranked by their market capitalization.

Company	Market Cap
Ifishdeco PT JK:IFSH	$170.16 Million
MIRC Electronics Limited NSE:MIRCELECTR	$170.22 Million
Gem Terminal Industry Co Ltd TW:2460	$170.32 Million
Digital Aria Co Ltd KQ:115450	$170.56 Million
Metsa Board Oyj A HE:METSA	$169.89 Million
Devyser Diagnostics AB ST:DVYSR	$169.83 Million
Landmark Bancorp Inc NASDAQ:LARK	$169.82 Million
Wallix Group SA PA:ALLIX	$169.74 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MEDICLIN Aktiengesellschaft's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 222,506,055 to 248,945,667, a change of 26,439,612 (11.9%).
Net income of 25,486,439 contributed positively to equity growth.
Dividend payments of 1,900,000 reduced retained earnings.
Other comprehensive income decreased equity by 9,206,000.
Other factors increased equity by 12,059,173.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€25.49 Million	+10.24%
Dividends Paid	€1.90 Million	-0.76%
Other Comprehensive Income	€-9.21 Million	-3.7%
Other Changes	€12.06 Million	+4.84%
Total Change	€-	11.88%

Book Value vs Market Value Analysis

This analysis compares MEDICLIN Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.72x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.20x to 0.72x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2003-12-31	€3.14	€3.76	x
2004-12-31	€2.69	€3.76	x
2005-12-31	€2.77	€3.76	x
2006-12-31	€3.13	€3.76	x
2007-12-31	€3.25	€3.76	x
2008-12-31	€4.59	€3.76	x
2009-12-31	€3.31	€3.76	x
2010-12-31	€3.47	€3.76	x
2011-12-31	€3.49	€3.76	x
2012-12-31	€3.31	€3.76	x
2013-12-31	€3.21	€3.76	x
2014-12-31	€3.25	€3.76	x
2015-12-31	€3.57	€3.76	x
2016-12-31	€3.83	€3.76	x
2017-12-31	€3.91	€3.76	x
2018-12-31	€4.03	€3.76	x
2019-12-31	€4.02	€3.76	x
2020-12-31	€3.73	€3.76	x
2021-12-31	€3.86	€3.76	x
2022-12-31	€4.40	€3.76	x
2023-12-31	€4.12	€3.76	x
2024-12-31	€4.68	€3.76	x
2025-12-31	€5.24	€3.76	x

Capital Efficiency Dashboard

This dashboard shows how efficiently MEDICLIN Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.24%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.25%
• Asset Turnover: 0.89x
• Equity Multiplier: 3.53x
Recent ROE (10.24%) is above the historical average (2.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2003	-17.16%	-4.51%	0.99x	3.84x	€-26.84 Million
2004	-19.53%	-4.44%	0.99x	4.44x	€-24.05 Million
2005	9.21%	2.10%	1.38x	3.18x	€-671.05K
2007	5.50%	1.46%	1.45x	2.59x	€-4.69 Million
2008	4.89%	1.59%	1.33x	2.31x	€-7.61 Million
2009	6.59%	2.20%	1.41x	2.12x	€-5.37 Million
2010	6.12%	2.07%	1.45x	2.04x	€-6.39 Million
2011	1.80%	0.60%	1.50x	1.99x	€-13.58 Million
2012	-0.89%	-0.28%	1.59x	2.03x	€-17.11 Million
2013	-1.73%	-0.51%	1.65x	2.05x	€-17.88 Million
2014	5.51%	1.58%	1.68x	2.07x	€-6.93 Million
2015	9.76%	2.98%	1.69x	1.94x	€-412.85K
2016	9.10%	2.85%	1.67x	1.91x	€-1.64 Million
2017	2.11%	0.64%	1.65x	1.99x	€-14.65 Million
2018	4.03%	1.20%	1.45x	2.32x	€-11.44 Million
2019	5.06%	1.44%	0.75x	4.70x	€-9.44 Million
2020	-5.08%	-1.36%	0.74x	5.01x	€-26.71 Million
2021	0.80%	0.22%	0.76x	4.81x	€-16.87 Million
2022	4.51%	1.34%	0.77x	4.38x	€-11.48 Million
2023	-5.50%	-1.48%	0.83x	4.49x	€-30.37 Million
2024	11.16%	3.32%	0.83x	4.07x	€2.59 Million
2025	10.24%	3.25%	0.89x	3.53x	€591.87K

Industry Comparison

This section compares MEDICLIN Aktiengesellschaft's net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $5,325,238,317
Average return on equity (ROE) among peers: -17.80%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
MEDICLIN Aktiengesellschaft (MED)	€249.63 Million	-17.16%	2.52x	$170.05 Million
China Resources Medical Holdings Company Limited (1PH)	$6.85 Billion	6.10%	0.53x	$405.05 Million
AEST.MED.INT.HLD.SP.ADR/3 (3FMA)	$9.35 Million	-213.41%	51.02x	$3.30 Million
JINXIN FERT.GRP HD-00001 (3NX)	$8.74 Billion	1.39%	0.74x	$656.44 Million
REVITALIST L.A.W. LTD (4DO)	$-11.05 Million	0.00%	0.00x	$744.60K
Wenzhou Kangning Hospital Co. Ltd (4WK)	$1.31 Billion	4.15%	1.31x	$19.28 Million
HYGEIA HC HLDGS DL-00001 (50I)	$6.78 Billion	2.43%	0.57x	$11.46K
COMPASS PATHW SP.ADR (5Y6)	$-52.85 Million	0.00%	0.00x	$657.30 Million
Bumrungrad Hospital Public Company Limited (BZ7A)	$14.79 Billion	24.52%	0.44x	$49.07K
Eifelhöhen-Klinik AG (EIF)	$14.69 Million	-6.59%	3.60x	$10.05 Million
Fresenius Medical Care AG & Co. KGaA (FME)	$14.83 Billion	3.37%	1.29x	$10.01 Billion

About MEDICLIN Aktiengesellschaft

XETRA:MED Germany Medical Care Facilities

Market Cap

$208.80 Million

€178.60 Million EUR

Market Cap Rank

#17277 Global

#1631 in Germany

Share Price

€3.76

Change (1 day)

+1.62%

52-Week Range

€2.86 - €4.02

All Time High

€6.64